Melatonin for Pulmonary Hypertension in Full Term Neonates
Status:
COMPLETED
Trial end date:
2025-03-15
Target enrollment:
Participant gender:
Summary
Published evidence has provided a possible role of melatonin and the treatment of pulmonary hypertension through its strong antioxidant properties and improving vascular function in animals.
This study will test the hypothesis of the possible use of melatonin as an adjunct therapy to milrinone for neonatal pulmonary hypertension.